SCHEMBL31115464

SCHEMBL31115464

O=C1Nc2c(ccc3c2CCO3)C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CES1 P23141 6/20 0.42
▸ DAO P14920 2/20 0.39
▸ NSD2 O96028 1/20 0.39
▸ BCHE P06276 1/20 0.39
▸ CDK1 P06493 1/20 0.37
▸ MAPKAPK2 P49137 1/20 0.37
▸ MAOA P21397 2/20 0.36
▸ MAOB P27338 2/20 0.36
▸ LIG1 P18858 1/20 0.36
▸ FABP6 P51161 1/20 0.33
▸ CLK1 P49759 2/20 0.33
▸ DYRK1A Q13627 2/20 0.33
▸ DYRK1B Q9Y463 2/20 0.33
▸ CSNK2A2 P19784 1/20 0.33
▸ CSNK2B P67870 1/20 0.33
▸ CSNK2A1 P68400 1/20 0.33
▸ DYRK2 Q92630 1/20 0.33
▸ CLK2 P49760 1/20 0.33
▸ CLK3 P49761 1/20 0.33
▸ MEN1 O00255 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4830542 1.00 CES1 (0.42) CES1DAONSD2BCHECDK1
SCHEMBL29091616 0.73 CES1 (0.42) CES1DAONSD2BCHEMAOA
SCHEMBL8330690 0.72 CES1 (0.44) CES1DAONSD2BCHEMAOA
SCHEMBL24104845 0.71 CES1 (0.43) CES1DAONSD2BCHELIG1
SCHEMBL12463566 0.70 ACHE (0.50) CDK1MAPKAPK2FABP6
SCHEMBL31355589 0.70 TGM2 (0.46) CES1CASP7TGM2DNMT1
SCHEMBL2251074 0.69 PARP1 (0.57) CES1DAONSD2BCHEMAOA
SCHEMBL2254584 0.69 PARP1 (0.53) CES1DAONSD2BCHELIG1
SCHEMBL8329359 0.68 CES1 (0.43) CES1DAONSD2BCHEMAOA
SCHEMBL8473758 0.67 PTPRC (0.42) CES1BCHEMAOAMAOBDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119330941-A Antitumor compounds as UPR agonists and uses thereof 南京圣和药业股份有限公司 2025-01-21 — — CN disclosed
CN-115697994-B Fused quinazoline derivative, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2024-08-13 — — CN disclosed
Send feedback